Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. 2006

Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
Department of Psychology, University of Pittsburgh, 3131 Sennott Square, 210 South Bouquet Street, Pittsburgh, PA 15260, USA. xiuliu@pitt.edu

BACKGROUND Smoking-related environmental stimuli have been implicated as an important factor in triggering relapse in abstinent tobacco smokers, and recent evidence indicates that drug-associated stimuli can reinstate nicotine-seeking in rats. However, there is little investigation on the factors that contribute to the latter effect. OBJECTIVE This study examined whether a nicotine-associated visual stimulus (VS) can reinstate nicotine-seeking after extinction in a response-reinstatement model of relapse, and whether the behavioral effects of the VS are sensitive to pharmacological blockade of nicotinic neurotransmission. It also determined whether active lever reassignment after food training influences nicotine self-administration and the VS-induced reinstatement. METHODS Male Sprague-Dawley rats were trained to self-administer nicotine (0.03 mg/kg/infusion, IV) and associate a VS with each nicotine infusion in 30 daily 1-h sessions. Half of the animals received nicotine infusions for responding at the same lever that previously delivered food; for the other half, infusions resulted from pressing the previously inactive lever during food training. Then, the nicotine-maintained response was extinguished by saline substitution and withholding the VS. One day after rats reached extinction criterion, the reinstatement tests were conducted where the VS was response-contingent represented without further delivery of nicotine. In pharmacological tests, a nicotinic antagonist, mecamylamine, was subcutaneously administered 30 min before reinstatement sessions. RESULTS Presentation of the nicotine-associated VS significantly reinstated responding at the previously drug-reinforced lever and pretreatment with mecamylamine effectively attenuated the response-reinstating effect of the VS. Additionally, animals showed similar profiles of nicotine-taking and nicotine-seeking behavior regardless of reassignment of the active lever after food training. CONCLUSIONS Nicotine self-administration and the VS-induced reinstatement of nicotine-seeking do not result from a lever bias due to prior experience for food reinforcement. Significantly, these results suggest that environmental stimuli associated with nicotine self-administration can effectively elicit nicotine-seeking behavior in abstinent subjects, that this effect is blocked by nicotine antagonism, and that the present procedures may be useful for studying neurobiological mechanisms of nicotine-seeking behavior and relapse.

UI MeSH Term Description Entries
D008297 Male Males
D008464 Mecamylamine A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
D009042 Motivation Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli. Incentives,Disincentives,Expectations,Disincentive,Expectation,Incentive,Motivations
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012055 Reinforcement Schedule A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. Reinforcement Schedules,Schedule, Reinforcement,Schedules, Reinforcement
D003463 Cues Signals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond. Cue
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005108 Extinction, Psychological The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. Psychological Extinction,Extinction (Psychology),Extinctions (Psychology),Extinctions, Psychological,Psychological Extinctions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
May 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
January 2020, Frontiers in pharmacology,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
May 1997, Psychopharmacology,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
January 2002, Respiration; international review of thoracic diseases,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
May 2001, Behavioural brain research,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
June 2011, Behavioural pharmacology,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
April 2012, Psychopharmacology,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
January 2018, Addiction biology,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
March 2000, Pharmacology, biochemistry, and behavior,
Xiu Liu, and Anthony R Caggiula, and Susan K Yee, and Hiroko Nobuta, and Russell E Poland, and Robert N Pechnick
July 2003, Psychopharmacology,
Copied contents to your clipboard!